Rizzo A, Zayed A, Vitale E, Buti S, Takeshita H, Crabb S, Roviello G, Seront E, Tapia JC, Scagliarini S, Popovic L, Kopp RM, Abahssain H, Rizzo M, Monteiro FSM, Massafra R, Brunetti O, Santini D, Ürün Y, Montironi R, Mollica V, Massari F, Soares A, Santoni M. Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset. Clin Exp Metastasis. 2025 Sep 06; 42(5):52.

Polites SF, Aldrink JH, Lautz TB, Vierkant RA, Ragan MV, Reiter A, Chen SY, Kim ES, Rinehardt HN, Malek MM, Fleming AM, Murphy AJ, Roach JP, Radhakrishnan S, Kastenberg ZJ, Piche N, Osman Y, Iii HNL, Tracy ET, Favela J, Le HD, Marquart J, Craig B, Lal DR, Seemann N, Petroze R, Rich BS, Glick RD, Selesner L, Yoo A, Fialkowski E, Brown EG, Boehmer C, Dasgupta R, Langham MR. Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection. Pediatr Blood Cancer. 2025 Dec; 72(12):e32029.

Reese T, Björk D, Longva AMH, Kiim KS, Evers M, Larsen PN, Schultz NA, Røsok BI, Carling U, Holmquist F, Lindell G, Sandström P, Böcker J, Gilg S, Engstrand J, Sturesson C, Oldhafer KJ, Björnsson B, Sparrelid E. Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases. Br J Surg. 2025 Sep 02; 112(9).

Hasselgren K, Williamsson C, Wennerblom J, Ghorbani P, Liljefors MG, Huhta H, Heby M, Månsson C, Johansson MI, Elander NO, Nortunen M, Kallio R, Halimi A, Öhlund D, Sandström P, Sparrelid E, Björnsson B. Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. BMC Surg. 2025 Jul 19; 25(1):299.

Sterner J, Andersson M, Olofsson A, Jansson H, Strömberg C, D'Souza M, Sturesson C, Sparrelid E, Gerling M, Gilg S, Engstrand J. Impact of post-hepatectomy liver failure on recurrence following major hepatectomy for colorectal cancer liver metastases. HPB (Oxford). 2025 Oct; 27(10):1309-1317.

Akabane M, Kawashima J, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. International validation of a natural-killer-cell-based model to predict recurrence-free survival in hepatocellular carcinoma. HPB (Oxford). 2025 Oct; 27(10):1259-1269.

Perri G, Engstrand J, Wright RD, Bronzwaer SFC, Kroese TE, Huang B, Acidi B, Vitale A, Tran Cao HS, van Hillegersberg R, Nilsson M, Sparrelid E, Katz MHG, Marchegiani G, Cillo U. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 Jul 01; 9(4).

Kawashima J, Endo Y, Khalil M, Woldesenbet S, Akabane M, Ruzzenente A, Ratti F, Marques H, Oliveira S, Balaia J, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh TJ, Aldrighetti L, Endo I, Pawlik TM. Development and validation of a preoperative risk prediction model for severe complications and very early recurrence after liver resection for hepatocellular carcinoma. Surgery. 2025 Sep; 185:109527.

Akabane M, Kawashima J, Woldesenbet S, Lee GR, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Distinct patterns of late recurrence in long-term hepatocellular carcinoma survivors. J Gastrointest Surg. 2025 Sep; 29(9):102135.

Altaf A, Baldo A, Khalil M, Rashid Z, Akabane M, Zindani S, Sarfraz A, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Lam V, Hugh T, Gleisner A, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer. World J Surg. 2025 Aug; 49(8):2195-2206.